Nicaragua vs Vietnam: HIV expenditure on prevention and treatment
Nicaragua
0 constant 2019 US$
in 2022
Vietnam
0 constant 2019 US$
in 2022
Nicaragua rank
101st
Vietnam rank
101st
HIV expenditure on prevention and treatment over time
- Nicaragua
- Vietnam
How they compare
Nicaragua currently reports 0 constant 2019 US$ against 0 constant 2019 US$ in Vietnam, a difference of 0 constant 2019 US$.
Across all 8 years both countries report, Vietnam has been ahead every year.
Nicaragua ranks 101st and Vietnam ranks 101st of 144 countries.
Vietnam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nicaragua | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.83 million constant 2019 US$ | 87.55 million constant 2019 US$ | 73.72 million constant 2019 US$ | Vietnam |
| 2010s | 6.22 million constant 2019 US$ | 34.81 million constant 2019 US$ | 28.59 million constant 2019 US$ | Vietnam |
| 2020s | 0 constant 2019 US$ | 0 constant 2019 US$ | 0 constant 2019 US$ | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv expenditure on prevention and treatment, Nicaragua or Vietnam?
- Nicaragua, at 0 constant 2019 US$ against 0 constant 2019 US$ in Vietnam as of 2022.
- What is the difference in hiv expenditure on prevention and treatment between Nicaragua and Vietnam?
- 0 constant 2019 US$, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Vietnam?
- 8 years are reported by both, from 2007 to 2022.
- How do Nicaragua and Vietnam rank globally for hiv expenditure on prevention and treatment?
- Nicaragua ranks 101st and Vietnam ranks 101st of 144 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV expenditure on prevention and treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Total in-country spending on HIV programs and services.